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Abstract Compared to other industrialized countries, the U.S. spends most of all on health
care. Nonetheless, the U.S. ranks relatively low on health care indicators. This paradox has
been already known for decades. For example, the turning point comparing the U.S. and
Canada was in 1972. Health expenditure as a percentage of GDP was higher in Canada than
in the USA from 1960 until 1972. Since 1972 expenditure on health care has been higher
in the U.S. than in Canada (OECD 2005a, Health data 2005, fourteenth OECD electronic
database on health systems, date of release June 2005, last update 04/26/2005). The present
study integrates the dispersed literature on spending and health care rankings and adds some
statistical analysis to these studies. The evaluation of different factors influencing health care
expenditure in the U.S. relative to other countries is restricted to a comparison with Canada.
The U.S. and Canada are two countries that are sufficiently similar to make comparisons
useful. The comparison of factors influencing health care expenditure in the U.S. and Canada
in 2002 reveals that health care expenditure in the U.S. is higher than in Canada mainly due
to administration costs, Baumol’s cost disease and pharmaceutical prices. It is not primarily
inefficiency in health care production but the dominant prevalence for free choice and own
responsibility that explains the paradox of high expenditure on health care and low ranking
on health care indicators.
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Introduction
Health care outlays in the U.S. were equal to 14.6% of Gross Domestic Product (GDP) in 2002
(OECD 2005a). Compared to other industrialized countries, the U.S. had the highest spending
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on health care, even though 14% of the population is uninsured in 2002 (NCHS 2004), whereas
other industrialized nations have comprehensive health insurance. The relatively high expen-
diture on health care implies neither that the U.S. provides more health care services than
other countries do (Anderson et al. 2003) nor that the U.S. ranks high on health care indi-
cators, such as infant, neonatal, perinatal and maternal mortality rates and life expectancy
(Starfield 2000; OECD 2005a). Concerning mortality rates and life expectancy, the U.S.
performs worse than, for example, Canada (OECD 2005a). It is clear that the relationship
between health care expenditure and health outcomes is complex (Nixon and Ulmann 2006).
The paradox of poor health records coupled with relatively high health care expenditure
in the U.S. in comparison to other Western countries has been known for decades (Newhouse
1993; Fuchs 2005). There is a large amount of literature concerning health care expenditure.
Health care rankings have been studied to a lesser extent.
Not only the relationship between health care spending and health outcomes, but also the
explanation of health care expenditure itself is complex. The explanation is multifactoral (e.g.
Reynolds 1989; Karatzas 2000; Sato 2001; Anderson et al. 2003, 2005; Sager and Socolar
2005) and according to Bodenheimer (2005b) varies in different historical periods.
This article integrates the dispersed studies on the topic by reducing the empirical esti-
mates of variables contributing to the relatively high health care expenditure in the U.S. to a
common denominator, GDP. It concentrates not only on factors that give an upward bias to
health care expenditure, but also includes factors with a downward bias on health care expen-
diture in the U.S. in comparison to other countries. For example the young population and
the high number of uninsured people are causes of lower health care expenditure in the U.S.
than in other countries. The negative and positive effects do not balance out. Consequently
health care expenditure is higher in the U.S. than in other countries.
This study quantifies the impact of different variables on health care spending as far as
possible for 2002. In some cases other years are presented due to lack of empirical data. In
addition to this restriction, the present study does not deal with all variables mentioned in the
literature. The selection of variables is made on the basis of the available empirical studies
and data. Fraud and rent seeking, for example, are not dealt with due to lack of empirical
information.
The decomposition of overall spending into components that can be traced to a distinct
set of explanatory factors lacks a single universally applicable, structural equation which
translates the various social, cultural, demographic and economic factors driving health care
spending into a nation’s overall, observable health care spending per capita. Even if such an
equation existed, a single equation for large countries such as the U.S. or Canada probably
would not exist either, although due to history and law, Canada’s provincial health systems
are more homogeneous than the vastly different regions within the U.S., across which health
spending per capita in any year varies more widely than per capita health spending across
the OECD. Therefore, the decomposition has a high degree of uncertainty around estimated
factor influences on overall spending.
To quantify the impact of different variables on health care expenditure in the U.S. in
comparison to other countries, I restrict the comparison to Canada, where health care expen-
diture is 9.6% of GDP, i.e., 5.0% points lower than in the U.S. in 2002 (OECD 2005a).
I have chosen Canada firstly because prior to the establishment of the National Health Insur-
ance at the end of 1960s Canada’s health care system was roughly the equivalent to the
U.S.’s (Newhouse 1993), and health care systems in several other countries are so different
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as to make comparisons nearly useless.1 Secondly, Canada and the U.S. are most likely to
influence each other, because both countries buy many of their health-systems inputs in the
same North American market area, and because medical training is interchangeable between
both countries. “With a common border, a common culture, and a common capitalist pen-
chant for profit making, Canada and the United States have forged closer economic links
than any other part of independent nations in the world” (Inglehart 2000).
Notwithstanding the mutual influences and the sharing of many cultural traits, in some
aspects the health care system in Canada differs nowadays significantly from the U.S. sys-
tem—for example, Canada has a publicly-funded and privately-administrated health care
financing system while the U.S. has a fragmented public–private health care financing system
(OECD 2005a). Additionally, the Canadian health care system is characterized by universal
coverage, i.e., health care is guaranteed to all of its citizens, while the U.S. is the only
industrialized nation in the world that does not guarantee health care for all citizens.2
Some factors which explain the relatively high health care expenditure in the U.S. are also
relevant for understanding the health status of U.S. citizens. The poor health of Americans
in comparison to citizens of other countries seems mainly attributable to income, which is
much more unequal in America than in other countries3 (World Bank 2005). The relationship
between income and health status is supported by several studies (Starfield 2000; Bach et al.
2004; BLS 2004; CMS 2004; Lafferty 2004; Raphael et al. 2005). Ross et al. (2001) extended
this relationship by incorporating segregation into their analysis. They found a relationship
between increased segregation “and increased mortality for the U.S. metropolitan areas.”
The present article decomposes health care expenditure into different supply and demand
factors. Several demand components, such as hospital care, are excluded from the analysis,
because the available data does not allow eliminating the potentially large double counting.
For example wage costs are also reflected in household expenditure on hospital care.
Health care expenditure in the U.S. is 5% points of GDP higher than in Canada (for
2002). The variables listed in Table 1, which are causing higher expenditure in the U.S. than
in Canada, explain between 3.01 and 4.88% points out of the total 5 point difference (see
Table 1).
The difference in health care expenditure between the U.S. and Canada is equal to 5.82–
6.16 GDP percentage points when health care expenditure is “corrected” for the relatively
high drug consumption and the uninsured in the U.S. Using this “corrected” figure as a
reference point, the unexplained difference in health care expenditure is approximately
1.28(= 6.16 − 4.88) to 2.81(= 5.82 − 3.01)% points of GDP. This can imply flaws in
the measurement of the differences but also that other factors are relevant.
The figures in Table 1 are only rough approximations of the magnitude of the differences.
There is some double counting, for example: the relatively high remuneration of health pro-
fessions (Baumol’s cost disease) in the U.S. is also reflected in the relatively high costs of
obesity and gun injuries, and the relatively high administration costs are also counted in the
1 It is to be expected that relationships at a micro level do not show up in aggregate data at a macro level when
there are significant differences in health care systems. This did not withhold researchers such as for example
Falaschetti (2005) and Delnoij et al. (2000) to implement large cross-country studies of health expenditure.
2 According to Birenbaum (2002), the American choice for a privately organized insurance system does not
imply that America offers more choice than Canada’s National Health Insurance system. In Canada patients
are allowed to use any provider in the system under the term of the insurance. It resembles the American
cost control through managed care, which has become the dominant form of financing and organization of
American health care.
3 The distribution of income is about 20% more equal in Canada than in the United States, namely the GINI
coefficient is 33 in Canada in 1998 and 41 in the USA in 2000 (World Bank 2005).
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Table 1 Summary determinants of health care expenditure in the U.S. in comparison with Canadian expen-
diture
Year In % of GDP
Difference Canada/U.S. 2002 −5.00
Supply factors
Investment 2000, 2002 −0.07 to −0.10
Pharmaceutical prices 2002 −0.22 to −1.00
(Caused by DTC advertising 2001 −0.03)
Baumol’s cost disease 2002 −0.76
(Net physician income 2002 <−0.43)
Administration costs 2002, 2003 −0.77 to −2.61
Law suits 2001, 2002 −0.14
Defensive medicine 2002 To be specified
(GP gatekeeper 1996 −0.03)
(Waiting lists 2002 −0.07)
Demand factors
Citizen’s incomea 2002 −0.05
(Private funding nursing homes 1999 −0.02)
Agea 2000 0.00
Insurance system To be specified
Uninsured 2001 0.34 to 0.68
Drug consumption 2002 −0.30 to 0.48
Tobacco consumption 1992 −0.02
Alcohol consumption 1992 −0.02
Obesity 2002 −0.16
Veterans 2002 To be specified
Gun injuries 2002 <−0.02
Sum of factors causing higher expenditure in the U.S. than in Canadab −3.01 to −4.88
Sum of factors causing lower expenditure in the U.S. than in Canadab 0.82 to 1.16
Legend:
a Income effect covers out-of-pocket expenditure by consumers only, i.e. it is exclusive public expenditure
b Calculation based on the biggest pharmaceutical price differential
() Not included in the summation because of double counting
expenditure on nursing homes. The sum of the different factors explaining the difference in
health care expenditure excludes double counting, as far as possible.
This article starts with a snapshot of the American health care system. It is followed by a
section dealing with supply factors such as investment, development of wages in relation to
productivity, administration costs and other cost containing institutions in health care, such
as managed care, the gatekeeping function of the general practitioner and waiting lists in
elective health care. It continues with a section dealing with demand factors such as income,
age, life styles and institutions such as the “peace-keeping” role of America. The final section
includes a conclusion and some discussion notes.
The Canadian and the American health care system
Canada’s single-payer health care system provides access to universal comprehensive cov-
erage for medically necessary health care services. Single-payer coverage in Canada permits
the use of global budgeting and rationing (Evans 2003). To provide health care the different
provinces contract directly with physicians and hospitals (Health Canada 2005). This system
resulted in public expenditure on health of 69.7% of total expenditure on health care in Canada
in 2002. The share of private funding of health care equals 30.3% of total expenditure on health
care. Private funding is made up firstly by pocket payments, secondly by private insurance,
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and thirdly by other private funds such as non-profit institutions serving households, philan-
thropic and charitable institutions. Their share in total health care expenditure is 15.3, 12.7 and
2.3% respectively (OECD 2005a). The U.S. in contrast has a mixed-private–public system.
Private health insurance in the U.S. is tax subsidized by Federal States. According to Enthoven
(2003), federal tax subsidies undermine cost-consciousness in the market for private health
insurance. The employer based insurance system in the U.S. resulted in public expenditure on
health care of 44.9% of total expenditure in health care. Private insurance covered 36.1% of
health expenditure, while out-of-pocket payments represent 14.1%, and other private funds
make up 4.9% of total health care expenditure in the U.S. in 2002 (OECD 2005a).
America’s health care system is mainly privately financed through an employer based
health insurance market (Rodriguez and Wiens-Tuers 2000). This employer based insurance
market provides insurance coverage to about two-thirds of the population under 65 years of
age. Insurance is universal for those over 65 years of age. In 1984 69.2% of the total population
under 65 years of age obtained health insurance through their workplace, which decreased
steadily (with a slight fluctuation in 1998) to 65.2 in 2002 (NCHS 2004). The insurance
provided to employees at the workplace is usually part of the compensation package. There
is a tax incentive for this type of coverage, because health benefits are not treated as taxable
incomes. 14% of the population is uninsured in 2002.
Health Maintenance Organizations (HMOs)4 and Preferred Provider Organizations
(PPOs)5 are the main providers of medical coverage. Together they insured 62% of all
full-time medical benefit participants in small private enterprises (less than 100 employees)
in 1996, and 73% in medium and large establishments (100 employees or more) in 1997. This
implies that most private health insurance is provided through some form of managed care
organization. The remaining part has medical coverage on a fee-for-service basis (NCHS
2004).
Besides employer based insurance, medical coverage is provided by the government,
through Medicare and Medicaid among others. Medicare is focused on the elderly and Med-
icaid is focused on the poor.
Finally, individuals can always choose private insurance themselves. This is an option
chosen by some self-employed persons, but some workers also purchase insurance plans on
their own from a source other than their employer (Rodriguez and Wiens-Tuers 2000).
Supply side determinants of health care expenditure
There is a wide range of studies concerning the explanation of health care expenditure:
Some studies integrate two or more different variables while other studies concentrate on
the analysis of separate variables. Investment, pharmaceutical prices, income in relation to
productivity, administration costs, law suits, direct-to-consumer advertising, primary care
and waiting lists are examined separately in the following sections.
4
“An HMO is a health care system that assumes or shares both the financial risks and the delivery risks
associated with providing comprehensive medical services to a voluntarily enrolled population in a particular
geographic area, usually in return for a fixed, prepaid fee. Pure HMO enrollees use only the prepaid capitates
health services of the HMO panel of medical care providers. Open-ended HMO enrollees use the prepaid
HMO health services but, in addition, may receive medical care from providers who are not part of the HMO
panel. There is usually a substantial deductible, copayment, or coinsurance associated with use of nonpanel
providers.” (NCHS 2004, p. 457)
5
“A PPO is a type of medical plan where coverage is provided to participants through a network of selected
health care providers (such as hospitals and physicians). The enrollees may go outside the network, but they
would pay a greater percentage of the cost of coverage than within the network.” (NCHS 2004, p. 475)
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Table 2 Total investment defined as business assets with an expected use of more than 1 year that generally
are depreciated, in health care in Canada and the U.S. in 2000 and 2002
2000 Canada 2000 U.S. 2002 Canada 2002 U.S.
Per capita in US$ purchasing power parity 118.54 184.14 145.23 204.71
In % of gross domestic product 0.42 0.52 0.49 0.56
Source: Author’s calculation based on: U.S. Census Bureau (2004b), OECD (2005b), NCHS (2004), Statistics
Canada (2005)
Table 3 Medical equipment per million population in Canada (2001) and the U.S. (2002)
Canada U.S.
Computed Tomography Scanners 9.8 13.1
Magnetic Resonance Imaging Units 4.2 8.6
Radiation therapy equipment (in 1997) 7.0 4.0
Lithotriptors 0.4 3.2
Mammographs 19.3 12.0
Source: OECD (2005a)
Investment in highly advanced technology
Health care expenditure in the U.S. is higher than in Canada, among other things, because
the U.S. invests 0.07% points of GDP more in health care business assets than Canada in
2002 (see Table 2).
U.S. invests relatively more in new technologies. This difference in capital formation is
reflected in the medical equipment ratios per million population (see Table 3).
The spread of new technologies is relatively unrestrained in the U.S. and consequently
many of these technologies are used to a greater extent in the U.S. than in other countries
(Bodenheimer 2005a). Assuming that country differences in medical equipment ratios per
capita also reflect differences in use of corresponding technologies, the figures in Table 3
suggest that conventional X-ray techniques are used more often in Canada than in the U.S.
and that modern high tech techniques are used relatively less often in Canada than in the U.S.
Pharmaceutical prices
Other than investment, the difference in health care expenditure between the U.S. and
Canada is explained by drug prices. U.S. drug prices were comparable to those in Can-
ada in 1992, but rose relatively fast in the 1992–2002 period. This is indicated, among other
things, by the fact that Canada’s net pharmaceutical prices for 249 molecules “are 33% lower
than U.S. prices net of discounts, and 40% lower ignoring discounts,” in 1999. “Netting out
exchange rate movements [in the 1990s], Canadian prices are only 14% lower than U.S.
Prices” (Danzon and Furukawa 2003). Consequently, assuming that this estimate is repre-
sentative for all pharmaceutical expenditure and that this estimate might be held constant,
expenditure on prescription drugs is 0.22% of GDP higher in the U.S., due to the absence
of price regulations, as does exist in Canada (Author’s calculation based on: Danzon and
Furukawa 2003; NCHS 2004). However, if Canadian pharmaceutical prices are 65% lower
(unweighted average of 12 commonly used pharmaceuticals) than in the U.S., as is suggested
by Burton (2003), expenditure on prescription drugs is 1.00% of GDP higher in the U.S. due
to the absence of price regulations.
Although the fact that price increases for pharmaceuticals in Canada were higher in the
5 years after the Canadian regulations for generic drugs in May 1993 than price increases
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in the 6 years before the introduction (Anis et al. 2003) suggests that price regulation has
no effect, it is still generally assumed that the threat of regulation of pharmaceutical prices
(Ellison and Wolfram 2001) or price regulation itself explain the difference in price increases
for pharmaceuticals in the U.S. and Canada.
To understand the lack of pharmaceutical price regulations in the U.S. it has to be taken
into account that one of the possible disadvantages of price regulation is that it probably has
a negative effect on the launch of new drugs: The number of new chemical entities launched
during the mid-late 1990s is 73 in the U.S., with a mean lag of 4.2 months, and 56 in Canada,
with a launch delay of 12.2 months (Danzon et al. 2003). In other words Canadian patients
have poorer access to new drugs (less than 5 years in the market), compared to patients in
the U.S. However, according to Angell (2004), this is not necessarily negative. Most pre-
scriptions of expensive “new” drugs push aside the old and cheaper ones, which are already
on the market. The “new” drugs are often so-called “me-too” drugs, i.e. minor variations of
pharmaceuticals already on the market.
Baumol’s costs disease
Besides investment and pharmaceutical prices, productivity in relation to income of health
care workers also partly explains higher health care expenditure in the U.S. in comparison
to Canada. Productivity in health care is difficult to improve because health care relies for
a large part on a direct face to face relation between the health care worker and the patient.
For example, washing a patient needs time that cannot be reduced beyond a certain point.
Assuming that wages in low productivity sectors must keep up with wages in high productiv-
ity sectors, prices for labor intensive goods or services will rise relatively to prices of goods
and services produced by the high productivity sectors (McPake et al. 2003). This is called
Baumol’s cost disease. Health care, where a large part of cost comes from staff looking after
patients, is a low productivity sector. If it is true that Baumol’s costs disease is overstated
because the “output” used in measuring the productivity in health care fails to capture major
improvements in quality (Newhouse 1993; Triplett and Bosworth 2003), focusing on one
country give biased results. For example Cutler et al. (2006) show that while the cost of
medical spending shot up from 1960 to 2000, largely as a result of the development and
wide-spread use of new medical techniques, the cost per quality-adjusted life year decreased.
However, even if the Baumol’s costs disease is overstated, a comparison between countries
seems to be justified. Firstly, the same measurement problems arise in the U.S. as well as in
Canada. Secondly, health indicators for both males and females, such as life expectancy at
birth and infant mortality rates, reveal that the quality of health care did not improve in the
U.S. in comparison to Canada in the 1960–2000 period (United Nations 2005).
Although it would be better to start from 1971 to calculate the Baumol’s costs disease,
because the turning point in health care expenditure in the U.S. in comparison to Canada
was in 1972, comparable data are not available for the whole period. Consequently, the cal-
culation is based on the period from 1987 onwards. In 1987 expenditure on health was 2.3%
points higher in the U.S. than in Canada, and in 2002 this difference was equal to 5% points
of GDP (OECD 2005a). The difference in growth of labor productivity and growth of wages
and salaries in Manufacturing and Health and social work is shown in Table 4.
If wages and salaries in Health and social work had followed the wage rise in Manu-
facturing in the U.S. than wages and salaries in health care would have risen by 3.68% per
year. This is 4.88% points per year more than the rise in productivity in Health and social
work would justify, where productivity was falling. This value is assumed here to reflect
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Table 4 Growth rates (in percentages) per year of value added and of wages and salaries per full time
equivalent (fte) employment, in Canada and the U.S., in the period from 1987 through 2002
1988–2002 1988–2002 Wages Difference between column 3
Productivity per fte and salaries per fte and 2 in percentage points
Manufacturing in the U.S. 4.06 3.68 −0.38
Health and social work in the U.S. −1.20 3.59 4.79
Manufacturing in Canada 2.38 3.05 0.67
Health and social work in Canada −0.46 2.88 3.34
Source: Author’s calculation based on: BEA (2005), OECD (2007, Tables 07040, 08064, 8040, 09132, 09108)
fte= full time equivalent of employment
Table 5 Remuneration of health professions in US$ PPP (Purchasing Power Parity), in the U.S. and Canada,
in 2000 (Canada is the average of year 1999 and year 2001)
U.S. Canada
Self-employed general practitioner 132,000 101,273
Specialists 200,000 150,554
Salaried hospital nurses 47,754
Source: OECD (2005a)
the Baumol’s costs disease in American health care in the period 1987–2002. In Canada the
effect is lower: it equals 3.51% points per year.
The Baumol’s costs disease of 4.88% per year in health care in the U.S. in the period
1987–2002 equals 2.31% points of GDP in the U.S. in 2002. The Baumol’s costs disease of
3.51% per year in health care in Canada in the period 1987–2002 equals 1.55% points of
GDP in Canada in 2002. Consequently, Baumol’s costs disease explains 0.76% points of the
difference between the share of health care expenditure in GDP in the U.S. and Canada.
Physician’s income
Baumol’s cost disease can be imputed partly to physician’s income. Physician’s income in the
U.S. is higher than in Canada (Fuchs and Hahn 1990; Anderson and Poullier 1999; Reinhardt
et al. 2002). Excluding practical expenses, in 2000 the remuneration of self-employed gen-
eral practitioners was US$ 132,000 and US$ PPP 101,273 in Canada (the average of the
remuneration in year 1999 and 2001 is taken for Canada) (OECD 2005a) (Table 5).
Reed and Ginsburg (2003) reported an average net physician income of US$ 187,000 in
1999 in the U.S. According to Fuchs and Hahn (1990), net physician income was about one-
third higher in the U.S. than in Canada in the mid-1980s. Keeping both figures constant for
2002, and given that 717,549 doctors were professionally active in 2002 (NCHS 2004), this
explains 0.43% of American GDP spending on health care in comparison to Canada (Author’s
calculation based on: NCHS 2004; Fuchs and Hahn 1990; Reed and Ginsburg 2003).
In reality the Baumol’s effect attributed to physician income is lower than calculated here.
The fact that physician income is lower in Canada may be because, among other things, the
fees of Canadian physicians are set by a monopsonist (province governments) while those in
the U.S. are more market driven.
Administration costs
Administration costs prove to be a significant variable to explain the difference in health
care expenditure between the U.S. and Canada. America’s health care is characterized by
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a fragmented payer system, while Canada has a single-payer system. The first has less
economies of scale in administration than the latter because competition among provid-
ers of health care, on the one hand, and competition among insurers of health care on the
other, result, among other things, in extra expenses in billing and administrative operations
of health care providers who have to deal with 100s of payers and different rules and prices.
Overhead costs in Canada’s single payer system are much lower than in the U.S.: OECD
Health Data reports 72 US$ PPP health care administration expenditure per capita in Canada
in 2002 and 367 US$ per capita in the U.S. in 2002. Total national administration costs in
health care are 0.77% points of GDP higher in the U.S. than in Canada (OECD 2005a).
Whereas the OECD definition of health care administration is restricted to the activities of
private insurers, central and local authorities and social security, Woolhandler et al. include
besides insurance overhead costs also employers’ costs of managing benefits and adminis-
tration costs of hospitals, practitioners’ offices, nursing homes and home care. Consequently
they report much higher figures than the OECD for 1999: “In the United States, health care
administration cost $294.3 billion, or $1,059 per capita [. . .] In Canada, health care adminis-
tration cost $9.4 billion, or $307 per capita [. . .] After exclusions, administration accounted
for 31.0% of health care expenditures in the United States, as compared with 16.7% of health
care expenditures in Canada” (Woolhandler et al. 2003). Using the same broad definition, this
big difference is also reported by Himmelstein et al. (2003): “The U.S. wastes more on health
care bureaucracy than it would cost to provide health care to all of the uninsured. Admin-
istrative expenses will consume at least $399.4 billion out of total health care expenditure
of $1,660.5 billion in 2003. Streamlining administrative overhead to Canadian levels would
save approximately $286.0 billion in 2003, $6,940 for each of the 41.2 million Americans
who were uninsured as of 2001. This is substantially more than would be needed to provide
full insurance coverage.”
Using Woolhandler’s et al. and Himmelstein’s definition of administration costs, admin-
istration costs explain 2.61% of U.S. GDP higher spending on health care in comparison to
Canada in 2003 (Author’s calculation based on Himmelstein et al. 2003; OECD 2005a).
Transaction costs: law suits
Not only administration costs, i.e. costs that arise in setting up and in operating the health
care system, but also transaction costs, i.e. costs that are involved in exchanging health care
insurances and services, determine health care expenditure. For example, insurance compa-
nies have high costs in determining the applicant risks and in preventing moral hazard of
the insured. Partly these costs are already incorporated in the previous section on adminis-
tration costs.6 They will not be discussed any further. The same goes for negotiating costs
for the employers (or individual applicants) and costs of monitoring how insurers treat their
employees. This section is limited to the costs considering liability of health care workers.
The costs of medical liability emerged from a long history of lawsuits. Since the mid
19th century lawyers and physicians in the United States found themselves adrift as com-
petitive agents, fiercely hustling for business of their own in the radically open professional
marketplace. “Under such wide-open circumstances, suits for malpractice [. . .] emerged as
a tempting new growth area for aggressive lawyers [. . .] The result was an explosion of
malpractice suits” (Mohr 2000). Although one would expect that rising malpractice suits
6 Savings on administration costs in single-payer systems arise not only from economies of scale but “rather,
they are due to the fact that single-payer systems do not engage in risk-selection and risk-rating of premiums.
Administrative costs are lower, as the government does not devote its energies to the avoidance of high-risk
individuals in the way unregulated private insurers in the U.S. do.” (Flood 2003, p. 20)
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Table 6 American health care expenditure due to Direct Written Medical Malpractice Insurance Premiums
(MMI)
1980 1990 1995 2000 2002
GDP in billion US$ 2,796 5,803 7,401 9,825 10,446
Premiums MMI in billion US$ 1.49 5.27 6.11 6.3 8.93
Premium MMI in % GDP 0.05 0.09 0.08 0.06 0.09
Source: Author’s calculation based on: AIR (2003); NCHS (2004)
also results in rising insurance premiums—as suggested in the media by statements that
physicians decry the rapidly rising cost of malpractice insurance, which is squeezing them
out of business and running up the costs to patients—first Baicker and Chandra (2004b)
“find that increases in malpractice payments made on behalf of physicians do not seem to
be the driving force behind increases in premiums. Second, increases in malpractice costs
(both premiums overall and the subcomponent factors) do not seem to affect the overall size
of the physician workforce, although they may deter marginal entry, increase marginal exit
and reduce the rural physician workforce. Third, there is little evidence of increased use of
many treatments in response to malpractice liability at the state level, although there may
be some increase in screening procedures such as mammography.” Direct written medical
malpractice insurance premiums amount to less than 1% of health costs (see Table 6).
According to Anderson et al. (2005) “The cost of defending U.S. malpractice claims,
including awards, legal costs, and underwriting costs, was an estimated $ 6.5 billion in
2001—0.46% of total health spending. In Canada, the [. . .] total cost [. . .] was $237 million
(PPP) in 2001—0.27% of total Canadian health spending.” This equals 0.06% of GDP in the
U.S. and 0.03% of GDP in Canada in 2001 (Author’s calculation based on Anderson et al.
2005; OECD 2005a).
The costs of medical liability are higher than the direct written medical malpractice insur-
ance premiums alone. Among other things, state costs and administration costs are involved.
Nationally, malpractice costs, including malpractice insurance premium costs, defending
costs and administration costs, totaled $24.4 billion in 2002 (TillingHast/Towers Perrin 2005).
These total national medical malpractice tort costs are 0.23% of GDP in 2002 (Author’s cal-
culation based on: TillingHast/Towers Perrin 2005; NCHS 2004). Assuming that the ratio of
total malpractice costs in the U.S. and Canada, as reported by Anderson et al. (2005) also
applies here, the total medical malpractice tort costs explain 0.14% GDP points of the higher
health care expenditure in the U.S. versus Canada.
The costs mentioned above only include the explicit costs of the malpractice system. The
costs do not include the cost of defensive medicine, i.e. medical tests, procedures or visits to
reduce exposure to malpractice liability (Studdert et al. 2005; Kessler et al. 2006). Although
these indirect costs are unknown, raw estimates are available. For example, according to
president Bush (2005a) “defensive medicine drains some $60 billion to $100 billion from the
economy [in 2003]. Defensive medicine raises medical bills for patients and increases insur-
ance costs for employers and it takes money away that small businesses could use to invest
and expand.” So, defensive medicine equals 0.57–0.96% of GDP. This estimate is based on a
study by Kessler and McClellan (1996). The findings have never been replicated. According
to the Congressional Budget Office (2003) “Most estimates are speculative in nature, rely-
ing, for the most part, on surveys of physicians’ responses to hypothetical clinical situations,
and clinical studies of the effectiveness of certain intensive treatments. Compounding the
uncertainty about the magnitude of spending for defensive medicine, there is little empirical
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Table 7 American health care expenditure due to direct-to-consumer advertising (DTC)
1995 1998 2000 2001 2002
GDP in billion $ 7,401 8,782 9,825 10,082 10,446
DTC advertising in billion $ 0.34 1.3 2.5 2.7
DTC advertising in % GDP 0.00 0.01 0.03 0.03
Source: Author’s calculation based on: Calfee (2002); NCHS (2002, 2004)
evidence on the effect of medical malpractice tort controls on spending for defensive medicine
and, more generally, on overall health care spending.”
Transaction costs: direct-to-consumer (DTC) advertising
Next to costs of medical liability, DTC advertising is also a form of transaction cost that
affects health care expenditure. The possibility of DTC advertising by pharmaceutical indus-
tries appeared in 1985, when the Food and Drug Administration (FDA) lifted its moratorium
on DTC advertising. Under the constraint that DTC ads must meet the same standards as
those aimed at professionals, DTC advertising gradually increased from $12 million in 1989
to $340 million in 1995. In 1997, the year that the FDA issued draft guidelines that paved
the way for DTC advertising on television, the constraints had been loosened. In the wake of
this policy change, DTC-advertising continued to accelerate, to $2.7 billion in 2001 (Calfee
2002), i.e., equivalent to 0.03% of GDP (see Table 7).
DTC advertising costs amount to only 20% of promotional spending for all drugs. Most
is targeted toward physicians (NCHS 2004). According to Scherer (2000) total prescription
drug advertising and promotional outlays in the U.S. market during 1997 was estimated to
be 18% of sales.
According to Angell (2004) excessive marketing expenditure is closely tied to excess
me-too drugs: “For decades, the big drug companies have spent far more on ‘marketing and
administration’ [. . .] than on anything else. Throughout the 1990s, for example, the top 10
drug companies in the world consistently spent about 35% of sales on marketing and admin-
istration, and only 11–14% on R&D. [. . .] Just looking at the top 10 U.S. companies in 2002,
expenditures for marketing and administration were 31% of sales, compared with only 14%
for R&D. That comes to an astonishing $67 billion dollars of their $217 billion in sales.”
Cost containment
There are several strategies to contain health care costs, including, among other things, the
strengthening of primary care practice and planning of elective health care. These devices
have been implemented to a higher degree in Canada than in the U.S. (Starfield 2002). If the
U.S. had implemented these productivity enhancing devices to the same degree as Canada,
productivity would have been higher and consequently Baumol’s cost disease would explain
less of the difference in health care expenditure.
Primary care
“Throughout the 1970s, primary care was loosely defined as basic medical services offered by
community practitioners. Physicians were reimbursed on a fee-for-service basis, and patients
had nearly unlimited choice. Most selected generalists on the basis of convenience and famil-
iarity, but were permitted to pursue second or specialist opinions freely” (Kanel 2002). This
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Table 8 Remuneration and “productivity” of medical doctors in 2002 in Canada and the U.S.
Canada U.S.
Remuneration specialist in US$ PPPa 152,559 200,000
Remuneration general practitioner in US$ PPPa 102,045 132,000
Surgical procedures in-patient-cases, per 1,000 population 42 87.7
Surgical procedures per specialist 38.18 60.29
Doctor’s consultations per capitab 6.2 8.9
Practicing specialists per capitac 1.1 1.5
Source: OECD (2005a)
Legend:
a US in year 2000
b Canada in year 2001
c Canada includes non-practicing physicians also
changed with the introduction of managed care, which was encouraged by the Health Main-
tenance Organization Act of 1973. The growth in (the number of) HMOs “accelerated in the
1970s and 1980s (from 3 million members in 1973 to more than 29 million in 1987) largely
through encouragement by business interests looking for a way to control their expenditures
for employee health benefits” (Institute of Medicine 1996).
In American HMO’s and PPO’s generalists are positioned as obligatory first-contacts for
all health services. The primary task of a general practitioner in his function as gatekeeper to
the health care system is the coordination of care by assessing the situation correctly, helping
the patient with a proper referral and integrating the outcome of the referral into the patient’s
ongoing care. “This important function of the primary provider prevents fragmentation of
care and the hit-or-miss nature of self referral to specialists and promotes comprehensive
care, for the patient as a whole person, not merely a set of parts” (Jones 2003). Consequently,
gatekeeping in primary care has the potential to reduce health care costs because it may reduce
hospitalization and it may facilitate a more appropriate use of specialists (Bodenheimer and
Fernandez 2005). Baicker and Chandra (2004a), ignoring possible differences in clinical
training of primary care workers, conclude that health care in U.S. states with most general
practitioners per capita is significantly cheaper per capita than in regions with heavier empha-
sis on specialist care. However, gatekeeping is also criticized because of possible negative
effects: The “term gatekeeper has taken on a different meaning in describing the main func-
tion of the primary care physician: to monitor, regulate, and control the use of medical and
related services by managed care organizations’ patients [. . .] In this version, the gatekeeper
function as carried out may not always be to the patient’s benefit” (Jones 2003). Patients may
view gatekeeping with suspicion because they fear that rationing (if not restricting) the use
of health care resources ultimately works to the detriment of their health. This may explain
some of the aversion to gatekeeping. But gatekeeping is not mandatory. If patients accept
that the deviation of the least costly pathway is shifted back to them (through out-of-pocket
surcharges, or co-payments) they can always opt for a more expensive pathway. So, at least
in theory, even under the HMOs patients retain free choice.
Starfield (2002) ranks the U.S. in the category of health care systems with a low primary
care and Canada in the category of intermediate primary care.7 One source of health care
cost containment resulting from stronger primary care is the difference in remuneration of
specialist and general practitioners. Remuneration for specialists is higher than for general
practitioners (see Table 8).
7
“Forty percent of Americans with health insurance report that they are in gatekeeping arrangements in which
their primary care physician controls their access to specialists,” in 1997 (Peter 1997).
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Table 9 Productivity in Health care in Canada and the U.S., in 2002
Canada U.S.
Number of acute care beds per 1,000 population 3.1 2.9
Acute care bed days per capita 1.0 0.7
Acute care occupancy rate in % of available beds 86.6 65.7
Number of practicing specialists per 1,000 population 1.1 1.5
Number of practicing physicians per 1,000 population 2.1 2.3
Source: OECD (2005a)
If a general practitioner’s referral were required to visit a specialist, health care expendi-
ture would be lowered because this would limit the number of surgical procedures and the
number of specialist consults.8 This hypothesis is endorsed by a study by Pati et al. (2005): “In
1996, annual total per capita health expenditures were about 3% lower for privately insured
adults enrolled in managed care gatekeeping plans than for those in indemnity plans [fee-for-
service health insurance]. With nearly 105 million adults enrolled in managed care gatekeep-
ing plans this would imply savings of about $2 billion in national health expenditures for this
group. [. . .] After multivariate adjustments for differences in sociodemographic and health
characteristics predicted expenditures varied by about 6% between managed care gatekeep-
ing and indemnity plan enrollees.” Because 105 million adults are enrolled in managed care,
and this is equal to 50% of all adults aged 20 and over, an extra $2 billion could have been
saved in 1996 if everyone was in managed care gatekeeping: this saving amounts to only 0.03
of GDP in 1996. However, this is a conservative estimate, because it only includes savings
due to higher process-quality. The estimate does not include the quality benefits of heavier
emphasis on primary care.
Waiting lists
Waiting lists can be the result of a policy to improve efficiency. In these cases, supply of
health care is artificially scarce, i.e. it is not immediately available because supply is man-
aged in a way to reduce underemployment of capital and labor as much as possible. Less
underemployment may result in lower prices.
A positive relation between waiting lists and productivity is endorsed by Siciliani and
Hurst (2005). They show that countries with long waiting list have the lowest number of
acute care beds, practicing specialists and physicians per 1,000 of population. This relation
is statistically significant.
Productivity in hospitals is higher in Canada than in the U.S, at least as far as indicated by
the number of specialists and the number of physicians per 1,000 of population. Productivity
is not higher when measured by the number of acute care beds per 1,000 of population (see
Table 9).
The relatively low number of acute care beds per 1,000 of population may be explained
by “the large share of activity that is carried out within the ambulatory care as opposed to the
acute care sector [. . .] It may also be explained by the remuneration system, usually based
on pay per case by Diagnosis Related Groups (DRGs) which encourages reduction in length
of stay” (Siciliani and Hurst 2005).
8 According to Barbara Starfield, a gatekeeping system of primary care also offers protection from unneces-
sary and potentially dangerous tests and therapies. According to her, the U.S. system of having free access to
high-powered specialists has negative side effects on the health status (Starfield et al. 2005).
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Table 10 Percentage of patients waiting for elective surgery more than 4 months for those with elective
surgery in the past 2 years, in Canada and the U.S.
1998 2001
Canada 12 27
U.S. 1 5
Source: Blendon et al. (2002)
Although one would expect that higher productivity rates eventually result in lower prices,
Bell et al. (1998) report that there is no relationship between waiting times and prices, with
the exception of a total knee replacement in the U.S.
Even though waiting lists for elective surgery9 are much shorter in the U.S. than in Canada
(see Table 10), the productivity gain of waiting lists is likely to be small: “Services that typi-
cally have queues in other countries account for only 3% of U.S. health spending” (Anderson
et al. 2005).
If the productivity gain of waiting lists is indicated by the 15.8% lower physician and
specialists ratio per 1,000 population in Canada than in the U.S. (OECD 2005a), total pro-
ductivity gain amounts to 0.07% of GDP (Author’s calculation based on: OECD 2005a;
NCHS 2004).
Demand side determinants of health care expenditure
Beside supply side factors there are also demand side factors that influence the amount of
resources diverted to health care (Sato 2001). Demand related factors include, for example,
income, age, uninsurance, fat intake and smoking.
Notwithstanding that the insurance system affects the costs of health care, as is mentioned
in the paragraph on the Canadian and the U.S. health care systems, the influence of the health
insurance arrangements on the costs of health care is not quantified here due to lack of data.
Prices in health care are subject to public policy in Canada and consequently influence supply
and demand. However, this effect cannot be compared with market equilibrium as generated
in the U.S. where the market for physicians’ services is not self-equilibrating in the usual
sense because of supplier induced demand (Evans 1974; Nallamothu et al. 2007). Even if
the data were available it would have to be corrected for Baumol’s cost disease since public
policy restrained the uncontrolled proliferation of Baumol’s cost disease in Canada.
Income and age
Usually, aggregate health expenditures are related to measures of national income. For exam-
ple the study by Poullier et al. (2002) offers robust evidence that cross-country health care
expenditure variation is largely attributable to variation in GDP. However, these results may
be biased by, among other things, Baumol’s costs disease. That is why the present analysis
sticks to Consumer Expenditure data.
Age has a concave relationship to health care consumption, i.e. newborns, young chil-
dren and the elderly get the most health care. However, the age of the head of a household
(consumer unit) and health care expenditure per household are related linearly. The present
9 Elective surgery: planned surgery that is not an emergency requiring hospital admission within 24 h; Emer-
gency admission: an unplanned admission to hospital due to unexpected illness or injury that requires urgent
care.
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Table 11 Expenditure on Health Care by total average expenditure and age in the U.S.: regression statistics
on the relation between average expenditure on Health Care per consumer unit, total average expenditure per
consumer unit, and age of head of the consumer unita for each income group before taxesb per age groupc, in
the U.S. Consumer Expenditure Survey in 2001–2002 (data are transformed to logarithmic values)
Value SE t-Value Beta Pr(>|t|)
(Intercept) −2.9737 0.3001 −9.9100 0.0000
Total expenditure 0.8684 0.0648 13.3975 0.514 0.0000
Age of head of the consumer unit 1.3943 0.0707 19.7097 0.756 0.0000
Residual standard error: 0.0889 on 49 degrees of freedom
Multiple R-squared: 0.929
F-statistic: 320.8 on 2 and 49 degrees of freedom, the p-value is 0
Source: Author’s calculation based on BLS (2004)
Legend:
a Age of head of the consumer unit: the head of the consumer unit is the first member mentioned by the
respondent when asked to “Start with the name of the person or one of the persons who owns or rents the
home” (BLS 2004)
b The distinct income groups are: less than $5,000; $5,000–9,999; $10,000–14,999; $15,000–19,999; $20,000–
29,999; $30,000–39,999; $40,000–49,999; $50,000–69,999; $70,000 and over
c The distinct age groups are: under 25, 25–34, 35–44, 45–54, 55–64 and 65 and over
analysis focuses on household expenditure and not on expenditure per person. Health care
expenditure per household proves to rise together with income and age. A regression anal-
ysis of expenditure on Health Care by income (measured by Total Average Expenditure of
consumer units per income-group before taxes) and by age (measured by the age of the head
of the consumer unit)10 shows that income together with age explain 93% of the spending
on Health Care per income group before taxes. Spending on health care includes health
insurance, medical services, drugs and medical supplies. The Betas are 0.514 and 0.765
respectively (see Table 11).
The finding that age of individuals is the prevailing explanation for outlays on Health
Care is plausible: Firstly, “As consumption increases with income, the marginal utility of
consumption falls rapidly while the value of extending life rises” in relation with aging
(Hall and Jones 2004). Secondly, aging of individuals is related not only to special diseases
but also to a longer period of recovery from an illness or an operation. Thirdly, different
studies on expenditure on Health Care show “that the last years of life, irrespective of how
long people live, are associated with high care consumption” (Batljan and Lagergren 2004).
Because most people die at an age of 65 and over, and because proximity to death has
a significant influence on health care outlays, it is not strange to find that expenditure on
health care rises with aging of population (Seshamani and Gray 2004; Batljan and Lagergren
2004).
Since income in the U.S. is 15.5% higher than in Canada, measured in GDP per capita in
Purchasing Power Parity (OECD 2005a) and the average age of the population is 1.2 years
higher in Canada than in the U.S. (Author’s calculation based on United Nations 2005),
firstly, out-of-pocket health care expenditure in the U.S. is 0.05% of GDP higher than in
Canada because of the income effect, and secondly, health care expenditure in the U.S. is
0.00% of GDP lower because of a relatively low share of aged people in population (Author’s
10 Health care expenditure is linearly related with income and age: the F values for income and age are
28.924 and 101.127 respectively. There is no multicollinearity: the individual t tests show that the partial
slope coefficients are statistically different from zero. The t values for income and age are 5.378 and 10.056
respectively.
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Table 12 Health Care Expenditure of the uninsured, in the U.S., in 2001
2001
Gross Domestic Product (GDP) in billion $ 10,082
Health Care Expenditure uninsured in billion $ 98.9
Number of uninsured in million persons 44.3
Health Care Expenditure of insured (including elderly) per capita in $ 5,382.00
Health Care Expenditure of uninsured per capita in $ 2,233.00
Additional Health Care Expenditure of uninsured when insured privately 33.9–68.7
or publicly in billion $
Additional Health Care Expenditure of uninsured in % GDP 0.34–0.68
Source: Author’s calculation based on: NCHS (2004) and Hadley and Holahan (2003a,b)
calculation based on: NCHS 2004; U.S. Census Bureau 2004a; BLS 2004).11 The difference
in the age structure of the Canadian and American population is so small that this does not
result in a noticeable impact on the differential spending of the two countries.
The finding that income and health care expenditure are positively related is not self-
evident. Poverty negatively affects the health status of individuals (Ross et al. 2001; Lopez
2004) and consequently the poor are more in need of health care than the rich. Therefore,
it is plausible to expect that lower income groups spend more on health care than higher
income groups. However, this is not supported by the empirical data. Consequently other
variables are at stake. The positive relation is likely a reflection of the institution that access
to sophisticated health care, expensive well-trained physicians and well-funded hospitals is
highly influenced by income. Additionally, aged people can be rich. As far as expenditure
on health care of the higher incomes is involved, the positive relation with age is indicated
by for example charges to “rich” residents in nursing homes, i.e. those residents with own
income or family support as the primary source of payment. These charges to rich residents
are 12.7% higher than average charges to residents in nursing homes in 1999. Higher charges
to the rich equals 0.02% of GDP in 1999 (Author’s calculation based on NCHS 2004).
The uninsured
Health care consumption of the uninsured is U.S. $98.9 billion in 2001 (Hadley and Holahan
2003a). Every uninsured person spends U.S. $3,149 less on health care, on average, than an
insured person in 2001. If the uninsured were insured (privately or publicly) additional health
care expenditure would be 0.34–0.68% of GDP higher than reported by the National Center
for Health Statistics (see Table 12).
Minorities with the lowest income have the highest uninsurance rates, (NCHS 2004) and
the uninsured receive less care and are more likely to suffer adverse consequences due to
delayed or postponed care. In consequence, access and quality problems in health care dis-
proportionately affect people at the bottom of the income ladder and this is reflected in heir
health status: Black or African American minorities prove to have lower life expectancy and
higher infant mortality rates than the white Americans (NCHS 2004).
11 Out-of-pocket expenditures
= 3.374473 = −2.9737 + (0.8684 ∗ 4.609349) + (1.3943 ∗ 1.682145)
Out-of-pocket expenditures with income effect
= 3.310959 = −2.9737 + (0.8684 ∗ 4.536209) + (1.3943 ∗ 1.682145)
Out-of-pocket expenditures with income and age effect
= 3.329554 = −2.9737 + (0.8684 ∗ 4.536209) + (1.3943 ∗ 1.695482)
[Absolute values are US$ 2,368; US$ 2,046; US$ 2,136 respectively].
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According to the U.S. Census Bureau more than one third of the uninsured in 2001 live in
households with annual incomes below US $ 25,000, almost one-third live in households with
annual incomes above $50,000 and one in five live in households earning more than $75,000
annually. The growth in the number of uninsured between 2000 and 2001 was highest among
family households earning more than $75,000 per year. This suggests that there is a high
degree of free choice about whether to have coverage.
“Using the income of health insurance units vs. household incomes changes the distribu-
tion of the newly uninsured markedly” (Holahan et al. 2003). The difference between both
indicators is that the health insurance unit is an individual or an entire family of dependents
while the household income also includes income of “sub-families or unrelated persons that
reside there. For example, the household could include more than one nuclear family, as
well as extended family relatives, e.g. grandparents, cousins, aunts, and uncles of the family
maintaining the household. Since a household includes all those who share a housing unit,
the incomes of several unrelated individuals sharing an apartment for example, would also
be counted together. These combined incomes for a single household are then assigned to
each person living in that household as if they were fully available for them to use” (Holahan
et al. 2003). The use of “health insurance unit” income, instead of household income, as a
reference unit for analyzing changes in insurance coverage between 2000 and 2001, results
in the biggest growth in the number of uninsured among units with incomes less than two
times the poverty level. Because both measures of income result in a growth in the number
of uninsured among people in the highest income bracket in 2001, it is clear that some free
choice still exists. Considering uninsurance among the lowest income brackets, it is likely
that this is not always by choice: Firstly, because employer based insurance plans are not
portable, employees lose their coverage as soon as they leave or lose their employment.
Secondly, some of the uninsured simply cannot afford the cost of coverage.
Cultural and behavioral variables
Besides income and age, “social interactions, culture, economic institutions, or the consump-
tion choices or well-being of others” also affect consumption (Ackerman 1997). Specific
factors influencing demand for health care in the U.S. are, among other things, the relatively
high rate of adults considered as overweight or obese (OECD 2005a) and the “peacekeeping”
role of the U.S. in the world. The latter is likely to have resulted in a relatively high number
of physically and psychologically wounded war veterans (for example those who served in
Vietnam and Iraq) and consequently in higher health care expenditure.
Aging of population and drug consumption
Money value of drug consumption proves to increase especially with age (Beta 0.881) (see
Table 13).
Given the positive relationship between money value of drug consumption and age, one
might expect lower drug consumption in America than in Canada because the age struc-
ture of the population in America is relatively young in comparison to Canada’s. However,
pharmaceutical prices in the U.S, are higher than in Canada. A comparison of drug consump-
tion between both countries requires a correction for price differences. Lower drug consump-
tion in the U.S. in comparison to Canada occurs if the price difference between the U.S. and
Canada is bigger than 33.3%. The section on pharmaceutical prices suggests that the differ-
ential is somewhere between 14 and 65%. Total spending at current prices is 0.52% points of
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Table 13 Money value of drug consumption, income and age, in the U.S., in 2001 (data are transformed to
logarithmic values)
Value SE t-Value Pr(>|t|) Beta
(Intercept) −2.1099 0.3351 −6.2966 0.0000
Income 0.4824 0.0724 6.2511 0.0000 0.272
Age 1.5984 0.0790 20.2349 0.0000 0.881
Residual standard error: 0.09928 on 49 degrees of freedom
Multiple R-squared: 0.9085
F-statistic: 243.2 on 2 and 49 degrees of freedom, the p-value is 0
Source: Authors’ calculation based on BLS (2004)
Table 14 Consumption of some health influencing items per capita, in the U.S., in 2002
Canada U.S.
Fat intake grams per day 146.2 156.5
Calories intake per day 3,589 3,774
Fruit and vegetables in kilos 250.5 238.0
Sugar in kilos 42.2 30.2
Protein intake in grams per day 105.0 114.0
Tobacco in grams per day (aged 15 and over) 1,432a 1,588
Alcohol in liters 7.8a 8.3
Source: OECD (2005a)
Legend: a 2001
GDP higher in America than in Canada in 2002. Price differences of 14, 33.3, and 65% respec-
tively result in a differential in the volume of health care spending on pharmaceuticals of 0.30,
0.00, and −0.48% points of GDP respectively (Author’s calculation based on OECD 2004).
(Un)healthy lifestyle
Medical literature (e.g. Chick 1998) proves that there is a relationship between bad habits
associated with lower classes (such as heavy drinking) and mortality. For example, higher
social class is associated with light/moderate drinking, while heavy drinkers tend to be found
in lower income households. Heavy drinking is associated with increased mortality.
Americans seem to do relatively bad concerning fat intake, calories intake, fruit and veg-
etables consumption, tobacco intake and alcohol consumption (see Table 14).
The figures on obesity in Canada are 53.9% lower than in the U.S. in 2002: 14.1% (the
arithmetic median of the data in 2001 and 2003) of the Canadian population and 30.6 of the
American population were obese in 2002 (OECD 2005a).
Estimates of costs of obesity-related diseases vary from approximately 6% of the national
health care expenditure in 1995 (Wolf 1998) to 9.1% of total annual U.S. medical expendi-
ture in 1998 (Finkelstein et al. 2003; Bhattacharya and Bundorf 2005), and approximately
10% in 2002 (WIN 2005; NCHS 2004). However, a recent study reports a more conservative
estimate: Between 1987 and 2002, the share of private health spending attributable to obes-
ity soared more than 10-fold, from $3.6 to $36.5 billion (Thorpe et al. 2005). $36.5 Billion
equals 1.24% of private health spending in 2002 (NCHS 2004). This conservative estimate
of obesity related expenditure results in a higher expenditure on health care in the U.S. than
in Canada of 0.16% points of GDP.
Finally, the figures in Table 14 indicate that tobacco and alcohol consumption is slightly
higher in the U.S. than in Canada. Although this could be due to the U.S. health care system
123
Health care expenditure and ranking on health care indicators 19
Table 15 Possible tobacco and alcohol consumption related mortality per 100,000 population, in the U.S., in
2001
Canada U.S.
Chronic liver diseases and cirrhosis 6.9 9.5
Malignant neoplasms of trachea, bronchus and lung 47.0 49.7
Acute myocardial infarction 48.6 50.3
Source: OECD (2005a)
being more effective in detecting and curing cancers, mortality caused by tobacco and alcohol
consumption is also higher in the U.S. than in Canada (see Table 15). This finding indicates
that there are relatively more heavy drinkers in America. Mortality rates would have been
lower if there were relatively more light drinkers in the U.S.
The direct health care costs related to alcohol and tobacco in Canada were 0.58% of GDP
in 1992 (Single et al. 1998). If alcohol consumption and tobacco consumption in Canada were
as high as in the U.S. in 2001 then Canadian direct health care costs would have been approx-
imately 0.02% of GDP higher for alcohol and tobacco consumption respectively (Author’s
calculation based on Single et al. 1998; OECD 2005a).
Veterans and deaths and injuries due to firearms
Finally, a large number of veterans and a large number of injuries due to firearms are two
possible factors contributing to the relatively high health care expenditure in the U.S. in
comparison to other countries.
The American Veterans Administration (AVA) coordinates American health care expen-
diture for veterans. This organization provides hospital care for military veterans through
the use of global budgets (Feldman and Lobo 1997). It is an example of a health care deliv-
ery system that enhances primary care (Ferrer et al. 2005). Health care expenditure by The
Department of Veterans Affairs accounts for 2.6% of total Federal spending for HIV-related
activities in 2002 and for 3.5% of total mental health expenditure on 2000 (NCHS 2004).
These shares are higher than the proportion of veterans in total population, which is about
0.9%. This indicates that HIV-related expenditure and mental health spending are relatively
high for veterans. Total health care expenditure by the Department of Veteran Affairs health
care expenditure is only 0.22% of GDP in 2002 (NCHS 2004; see also Cowman et al.
2004). Because these figures do not include all health care expenditure for veterans it cannot
be concluded that the health care expenditure of veterans is higher than average expen-
diture. This makes a comparison with the health care expenditure of veterans in Canada
meaningless.
As to health care expenditure in relation to firearms injuries there is only data for the U.S.
An estimated 30,424 firearms deaths12 (Miniño et al. 2006) and 58.841 nonfatal firearms
injuries13 (NCIP&C 2005) were reported in 2002. The mean medical cost per injury is about
$23,000. Given the number of injuries and the mean medical cost, gunshot injuries in the
U.S. produced $2.1 billion in medical costs in 2002. This equals 0.02% of American GDP
(Author’s calculation based on Cook et al. 1999; U.S. Census Bureau 2004b).
12 Of these deaths, 762 were unintentional, 17,108 were suicides, 11,829 were homicides, 243 were undeter-
mined and 300 were related to legal interventions or war (Miniño et al. 2006, p. 9).
13 Of these injuries, 17,579 were unintentional, 3,295 were self-harm, 37,321 were assaults, and 646 were
related to legal interventions (NCIP&C 2005).
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Conclusion and discussion
Supply factors seem to explain a larger part of health care expenditure than demand factors.
The difference in health care expenditure between the U.S. and Canada can mainly be attrib-
uted to administration costs and Baumol’s costs disease (see Table 1). The impact of other
factors may be small in relation to total health care expenditure, but most of them are still
substantial since every 0.01% of GDP equals a little more than 1 billion US$.
The different factors that explain the difference in health care expenditure primarily seem
to be a manifestation of the national cultures. The U.S. has a strong belief in individualism and
limited government, while Canada attaches great value “to communal obligations and a robust
public sector” (Inglehart 2000). American culture14 is more concerned about responsibility
for one’s own life or in other words about “microeconomic efficiency”, “freedom of choice
for consumers” and “appropriate autonomy for providers” than that it is concerned about
“adequacy and equity in access”, “income protection” (that is, “patients should be protected
from payments for health that represent catastrophic threats to their income or wealth”) and
“macroeconomic efficiency” (that is, cost control) (Hurst 1991). In other words, the market
is the dominating governance structure in U.S. health care while regulation of health care is
the more dominating governance structure in Canada. These features are most prominently
reflected in the insurance arrangements: the employer based insurance arrangements in the
U.S. and the single-payer arrangement in Canada. From this point of view, the relatively
high health care expenditure in the U.S. in comparison to other industrialized countries is
primarily a matter of choice of governance structure. Higher health care expenditures related
to the choice of governance structure in U.S. health care system include: firstly, high adminis-
trative costs that result from the differentiated payment system; secondly, the relatively high
remuneration of health care specialists; and thirdly the relatively high pharmaceutical prices.
Not only national differences in expenditures but also the relatively ranking on health care
indicators and the fact that millions of Americans are uninsured seem to be manifestations of
the overarching cultures. One of the elements of U.S. culture is that people are responsible for
their own income and wealth. Big income differentials are related to a culture of free choice
and own responsibilities. Because poverty negatively affects the health status of individuals,
higher income differentials in the U.S. relative to Canada, make the U.S. have a relatively
lower ranking on some health care indicators than Canada, and may well offset the effects
of the superior care made possible by the high tech investment.
The paradox of high health care expenditure and low ranking on health care indicators
persisting for decades seems to be rooted in the overarching culture, resulting in an unequal
distribution of income. The relatively unequal distribution of income in the U.S. seems to be
the crux behind the paradox. Improvements in microeconomic efficiency are likely to reduce,
14 The American medical system reflects the hallmarks of American culture. Firstly, American culture seems
to be characterized by a strong confidence in the blessings of individual economic independence. It is anchored
in the assumption that an individual, as far as economic matters are involved, knows better what is good for
him or her than someone else or whatever institute/authority. Attached to this assumption is the conviction that
everybody has an own responsibility in preparing him or herself for the challenges of life in a free society. This
includes among other things that health insurance is an individual responsibility. Secondly, American culture
seems to be qualified by an optimistic outlook on the future. Williamson (1985, p. 38) has formulated this as
follows “Workers and their families are irrepressible optimists. They are taken in by vague assurances of good
fait, by legally unenforceable promises and by their hopes for the good life. Tough-minded bargaining in its
entirety never occurs or, if it occurs, comes too late.” Both hallmarks of American culture are summarized
concisely by President Bush in his inauguration of 2005: “By making every citizen an agent of his or her own
destiny, we will give our fellow Americans greater freedom from want and fear, and make our society more
prosperous and just and equal” (Bush 2005b).
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but not solve, the paradox but will not solve the paradox as long as the U.S. keeps track with
free choice, competition etc. as benchmarks of health care.
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